Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)

被引：0
|
作者：
Mease, P. [1 ,2 ]
Kirkham, B. [3 ]
McInnes, I. B. [4 ]
Kremer, J. [5 ,6 ]
Kandala, S. [7 ]
Pricop, L. [8 ]
Mpofu, S. [9 ]
机构：
[1] Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Guys & St Thomas NHS Fdn Trust, London, England
[4] Univ Glasgow, Glasgow, Lanark, Scotland
[5] Albany Med Coll, Albany, NY 12208 USA
[6] Ctr Rheumatol, New York, NY USA
[7] Novartis Healthcare Pvt Ltd, Hyderabad, Andhra Pradesh, India
[8] Novartis Pharmaceut, Orange, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2015年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P115
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)
    Ruperto, N.
    Foeldvari, I.
    Alexeeva, E.
    Aktay Ayaz, N.
    Calvo, I.
    Kasapcopur, O.
    Chasnyk, V.
    Hufnagel, M.
    Zuber, Z.
    Schulert, G.
    Ozen, S.
    Popov, A.
    Ramanan, A.
    Scott, C.
    Sozeri, B.
    Zholobova, E.
    Zhu, X.
    Whelan, S.
    Pricop, L.
    Ravelli, A.
    Martini, A.
    Lovell, D. J.
    Brunneron, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 201 - 202
  • [22] Secukinumab improves physical function, quality of life, fatigue and work productivity in patients with active psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled phase 3 trial (FUTURE 2)
    Gottlieb, A. B.
    Strand, V.
    McInnes, I. B.
    Marzo-Ortega, H.
    Kavanaugh, A.
    Kandala, S.
    Pricop, L.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S30 - S30
  • [23] Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylarthritis As Well As Peripheral Arthritis: Results from 2 Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Kavanaugh, Arthur
    Puig, Luis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    You, Yin
    Li, Shu
    Song, Michael
    Randazzo, Bruce
    Rahman, Proton
    McInnes, Iain. B.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [24] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-year Results From a Phase 3, Multicenter, Double-blind, Placebo-controlled Study
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    SWISS MEDICAL WEEKLY, 2014, 144 : 8S - 9S
  • [25] Secukinumab Provides Sustained Improvements in Psoriatic Arthritis: 2-Year Efficacy and Safety Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
    Mease, Philip J.
    McInnes, Iain B.
    Kirkham, Bruce
    Kavanaugh, Arthur
    Rahman, Proton
    van der Heijde, Desiree
    Landewe, Robert B. M.
    Nash, P.
    Pricop, Luminita
    Wang, Zailong
    Mpofu, Shephard
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Kavanaugh, Arthur
    Puig, Luis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3324
  • [27] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 737 - 738
  • [28] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [29] A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AURANOFIN IN PATIENTS WITH PSORIATIC-ARTHRITIS
    CARETTE, S
    CALIN, A
    MCCAFFERTY, JP
    WALLIN, BA
    ARTHRITIS AND RHEUMATISM, 1989, 32 (02): : 158 - 165
  • [30] Alefacept in combination with methotrexate for the treatment of psoriatic arthritis - Results of a randomized, double-blind, placebo-controlled study
    Mease, Philip J.
    Gladman, Dafna D.
    Keystone, Edward C.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1638 - 1645
12345